Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Fund Letter | Christian RytherCurreen Capital | InsuranceInsurance | Short JXN (Jackson Financial Inc.) The manager exited a previously large position in Jackson Financial due to its high correlation with the performance of the S&P 500. Attempting to predict... | BEAR | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Joost van der MandeleVan Der Mandele Arar Fund | InsuranceInsurance | Long JXN (Jackson Financial Inc) Our biggest position is meant to be a boring American life insurer trading at a P/E of 4. | BULL | View Pitch → | |
| Aug 19, 2026 | Fund Letter | Joost van der MandeleVan Der Mandele Arar Fund | InsuranceInsurance | Van Der Mandele Arar Fund – JXN Jackson has a habit of moving up and down for strange reasons. It went down... | BULL | View Pitch → | |
| Feb 20, 2026 | Fund Letter | Joost van der MandeleVan Der Mandele Arar Fund | InsuranceInsurance | Van Der Mandele Arar Fund 2025 Q4 (JXN) Our biggest position is meant to be a boring American life insurer trading at a P/E of 4. In the case... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.